Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Weiss

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
JAMA Network Open|March 27, 2024
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple MyelomaJohn Devin Peipert, Fengmin Zhao, Ju-Whei Lee, et al.
The Lancet. Oncology|September 1, 2020
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trialShaji K Kumar, Susanna J Jacobus, Adam D Cohen, et al.
Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Clinical Immunology (Orlando, Fla.)|March 5, 2025
Autoantibody development is associated with clinical severity of COVID-19: A cohort studyMarie Brinkmann, Ludwig Traby, Manuel Kussmann, et al.
Cancer|August 28, 2024
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trialsSuzanne George, Nancy Campbell, Shauna L Hillman, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
JAMA Network Open|March 27, 2024
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple MyelomaJohn Devin Peipert, Fengmin Zhao, Ju-Whei Lee, et al.
The Lancet. Oncology|September 1, 2020
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trialShaji K Kumar, Susanna J Jacobus, Adam D Cohen, et al.
Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Clinical Immunology (Orlando, Fla.)|March 5, 2025
Autoantibody development is associated with clinical severity of COVID-19: A cohort studyMarie Brinkmann, Ludwig Traby, Manuel Kussmann, et al.
Cancer|August 28, 2024
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trialsSuzanne George, Nancy Campbell, Shauna L Hillman, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 14